xxtzez0e | Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/xxtzez0e_hasAnnotation_C0024299> <https://research.tib.eu/covid-19/entity/xxtzez0e_hasAnnotation_C2987634>
?:creator	<https://research.tib.eu/covid-19/entity/Cheadle%2C_E_J%3B_Lipowska-Bhalla%2C_G%3B_Dovedi%2C_S_J%3B_Fagnano%2C_E%3B_Klein%2C_C%3B_Honeychurch%2C_J%3B_Illidge%2C_T_M>
?:doi	<https://research.tib.eu/covid-19/entity/10.1038/leu.2017.218>
?:doi	10.1038/leu.2017.218
?:externalLink	<https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609297/>
?:journal	Leukemia
?:license	no-cc
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7609297>
?:pmid	<https://research.tib.eu/covid-19/entity/28751765>
?:pmid	28751765
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/xxtzez0e_HAS_C2742503_ASSOCIATED_WITH_C0024299> <https://research.tib.eu/covid-19/entity/xxtzez0e_HAS_C2987634_STIMULATES_C2742503>
?:source	PMC
?:title	Erratum: A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2017-07-28

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/xxtzez0e>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/xxtzez0e>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all